Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $142B |
| FY2017, ended Dec 31, 2017 | $164B |
| FY2018, ended Dec 31, 2018 | $104B |
| FY2019, ended Dec 31, 2019 | $132B |
| FY2020, ended Dec 31, 2020 | $129B |
| FY2021, ended Dec 31, 2021 | $147B |
| FY2022, ended Dec 31, 2022 | $157B |
| FY2023, ended Dec 31, 2023 | $146B |
| FY2024, ended Dec 31, 2024 | $187B |
| FY2025, ended Dec 31, 2025 | $250B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $297B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $75.0B |
| FY2017, ended Dec 31, 2017 | $78.1B |
| FY2018, ended Dec 31, 2018 | $79.8B |
| FY2019, ended Dec 31, 2019 | $77.9B |
| FY2020, ended Dec 31, 2020 | $76.0B |
| FY2021, ended Dec 31, 2021 | $82.2B |
| FY2022, ended Dec 31, 2022 | $80.7B |
| FY2023, ended Dec 31, 2023 | $35.2B |
| FY2024, ended Dec 31, 2024 | $37.9B |
| FY2025, ended Dec 31, 2025 | $40.6B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $43.1B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $6.97B | $6.91B |
| FY2017, ended Dec 31, 2017 | $6.04B | $7.36B |
| FY2018, ended Dec 31, 2018 | $7.91B | $8.04B |
| FY2019, ended Dec 31, 2019 | $7.18B | $9.24B |
| FY2020, ended Dec 31, 2020 | $8.06B | $9.21B |
| FY2021, ended Dec 31, 2021 | $9.11B | $11.2B |
| FY2022, ended Dec 31, 2022 | $9.05B | $9.73B |
| FY2023, ended Dec 31, 2023 | $7.81B | $7.88B |
| FY2024, ended Dec 31, 2024 | $7.06B | $10.8B |
| FY2025, ended Dec 31, 2025 | $11.3B | $10.7B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $10.7B | $13.6B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $4.24B |
| FY2017, ended Dec 31, 2017 | $8.45B |
| FY2018, ended Dec 31, 2018 | $6.59B |
| FY2019, ended Dec 31, 2019 | $6.86B |
| FY2020, ended Dec 31, 2020 | $7.28B |
| FY2021, ended Dec 31, 2021 | $4.50B |
| FY2022, ended Dec 31, 2022 | $3.21B |
| FY2023, ended Dec 31, 2023 | $3.06B |
| FY2024, ended Dec 31, 2024 | $4.22B |
| FY2025, ended Dec 31, 2025 | $4.87B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $6.68B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $29.1B |
| FY2017, ended Dec 31, 2017 | $34.3B |
| FY2018, ended Dec 31, 2018 | $31.8B |
| FY2019, ended Dec 31, 2019 | $31.0B |
| FY2020, ended Dec 31, 2020 | $31.5B |
| FY2021, ended Dec 31, 2021 | $27.8B |
| FY2022, ended Dec 31, 2022 | $43.1B |
| FY2023, ended Dec 31, 2023 | $47.9B |
| FY2024, ended Dec 31, 2024 | $45.7B |
| FY2025, ended Dec 31, 2025 | $48.8B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $47.6B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 0.5% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.55B |
| FY2017, ended Dec 31, 2017 | 1.55B |
| FY2018, ended Dec 31, 2018 | 1.55B |
| FY2019, ended Dec 31, 2019 | 1.56B |
| FY2020, ended Dec 31, 2020 | 1.56B |
| FY2021, ended Dec 31, 2021 | 1.55B |
| FY2022, ended Dec 31, 2022 | 1.55B |
| FY2023, ended Dec 31, 2023 | 1.55B |
| FY2024, ended Dec 31, 2024 | 1.55B |
| FY2025, ended Dec 31, 2025 | 1.56B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 1.56B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back |
|---|---|
| FY2016, ended Dec 31, 2016 | $0 |
| FY2017, ended Dec 31, 2017 | $0 |
| FY2018, ended Dec 31, 2018 | — |
| FY2019, ended Dec 31, 2019 | $0 |
| FY2020, ended Dec 31, 2020 | $0 |
| FY2021, ended Dec 31, 2021 | $775M |
| FY2022, ended Dec 31, 2022 | $209M |
| FY2023, ended Dec 31, 2023 | $0 |
| FY2024, ended Dec 31, 2024 | $0 |
| FY2025, ended Dec 31, 2025 | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | — |
Valuation
At current price- Market Cap
- $316B
- P/E
- 29.5×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 7.3×
- Price / Book
- n/m. Market cap / shareholders' equity
- EV / EBITDA
- 19.1×
Growth
Trailing 12 months- Revenue (TTM)
- $43.1B
- Revenue Growth YoY
- 7.9%
- Revenue CAGR 3Y
- −20.4%
- Revenue CAGR 5Y
- −11.8%
- EPS Growth YoY
- 24.1%
- Net Income Growth YoY
- 24.1%
Profitability
Trailing 12 months- Gross Margin
- 67.7%
- Operating Margin
- 38.6%
- Net Margin
- 24.8%
- FCF Margin
- 31.5%
- Return on Equity
- n/m. Net income (TTM) / average equity
Earnings
Trailing 12 months- Net Income
- $10.7B
- EPS (diluted)
- $6.85
- EBITDA
- $18.7B
- Operating Income
- $16.7B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $6.68B
- Total Debt
- $47.6B
- Net Debt
- $40.9B
- Total Assets
- $66.7B
- Total Liabilities
- $72.7B
- Shareholders' Equity
- −$7.94B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $15.2B
- Capital Expenditure
- $1.56B
- Free Cash Flow
- $13.6B
Dividends and risk
Last 12 months- Dividend Yield
- 3.0%
- Dividend / Share
- $6.01
- Beta (5Y)
- 0.34
Every ratio is calculated from the company’s reported figures.